Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticoid therapy: how?

R Rubens1

  • 1Department of Endocrinology, State University Hospital, Gent, Belgium.

Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

High-dose glucocorticoids can suppress the pituitary adrenal axis. Careful tapering of corticosteroid therapy is essential for adrenal recovery, confirmed by cortisol levels and stress response tests.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic fatigue syndrome in the psychiatric practice.

Acta neuropsychiatrica·2016
Same author

Do not resuscitate in the critically ill.

Acta clinica Belgica·2008
Same author

Prevalence and demography of transsexualism in Belgium.

European psychiatry : the journal of the Association of European Psychiatrists·2006
Same author

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2005
Same author

Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Journal of endocrinological investigation·2002
Same author

Surgical therapy in transsexual patients: a multi-disciplinary approach.

Acta chirurgica Belgica·2002
Same journal

Didactic image poppers maculopathy.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Marcus Gunn Syndrome. Study of 3 rare cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Ocular manifestations of children living with HIV/AIDS in Kinshasa].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Management of rhegmatogenous retinal detachment with unseen breaks: about 50 cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

Long term IOP lowering efficacy of bimatoprost/timolol fixed combination: a 12 month prospective study.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Palpebral pilomatricoma simulating a chalazion in a young adult].

Bulletin de la Societe belge d'ophtalmologie·2014
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Corticosteroids are potent medications with significant physiological effects.
  • High-dose glucocorticoid use can lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis.
  • Understanding the relative potencies of different corticosteroid preparations is crucial for safe and effective management.

Purpose of the Study:

  • To outline the principles of corticosteroid equivalency and dosing.
  • To describe a safe tapering strategy for long-term corticosteroid therapy.
  • To detail methods for assessing HPA axis recovery following corticosteroid withdrawal.

Main Methods:

  • Equivalency of hydrocortisone, prednisolone, and dexamethasone established.
  • Dose individualization based on the underlying disease.

Related Experiment Videos

  • Gradual reduction of corticosteroid dosage over an extended period (tapering).
  • Transition to physiological hydrocortisone replacement during tapering.
  • Monitoring of basal cortisol levels and dynamic testing (ACTH stimulation, insulin tolerance test) to assess adrenal function.
  • Main Results:

    • Knowledge of corticosteroid equivalency (e.g., hydrocortisone 1, prednisolone 4, dexamethasone 25) is necessary for dose adjustment.
    • Long-term corticosteroid therapy (duration > 6 weeks, dose > 7.5 mg prednisolone equivalent daily) requires a prolonged and careful tapering phase.
    • Initial switch to a physiological hydrocortisone replacement regimen (20/10 mg daily) is recommended during tapering.
    • Adrenal recovery is assessed by monitoring basal cortisol and performing dynamic tests.

    Conclusions:

    • Effective management of corticosteroid therapy necessitates understanding drug equivalencies and adapting doses to specific diseases.
    • A structured tapering protocol, including physiological replacement and regular adrenal function testing, is vital for successful HPA axis recovery after prolonged glucocorticoid use.
    • Confirmation of adrenal recovery is established only after demonstrating a sufficient stress response through dynamic testing, such as the insulin tolerance test.